Table 1.

Mice used in the study.

Group	Number of Mice Used for Experiments	Mortality Rate	Number of Mice Used in the Figures
Figure 1 and Figure 2	naive LCN2+/+: 3	0	3
(staining)	LCN2+/+ tMCAo: 3	0	3
Figure 3B,C	naive LCN2+/+: 3	0	3
(Immunoprecipitation–Western)	naive LCN2−/−: 3	0	3
	LCN2+/+ tMCAo: 3	0	3
	LCN2−/− tMCAo: 3	0	3
Figure 3E,F (ELISA)	LCN2+/+ tMCAo: 10	0	10
	LCN2+/+ tMCAo-Ab: 10	1/10 (10.0%)	9
Figure 3D and Figure 6	naive LCN2+/+: 6	0	6
(real-time RT-PCR)	naive LCN2−/−: 6	0	6
	LCN2+/+ tMCAo: 8	2/8 (25.0%)	6
	LCN2−/− tMCAo: 7	1/7 (14.3%)	6
	LCN2+/+ tMCAo-Ab: 7	1/7 (14.3%)	6
Figure 4A–E (TTC staining)	LCN2+/+ tMCAo: 8	1/8 (12.5%)	7
	LCN2+/+ tMCAo-Ab: 8	1/8 (12.5%)	7
Figure 5A,B (blood–brain barrier (BBB))	LCN2+/+ tMCAo: 6	1/6 (16.6%)	5
	LCN2+/+ tMCAo-Ab: 6	1/6 (16.6%)	5
Figure 5C–F	LCN2+/+ tMCAo: 4	0	4
(BBB–Western)	LCN2+/+ tMCAo-Ab: 4	0	4
Total	108	9/108 (8.3%)	99